Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition-Reference-Cited by-同舟云学术

Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition

Published:2014-11-17 Issue:12 Volume:6 Page:1084-1090
ISSN:1755-4330
Container-title:Nature Chemistry
language:en
Short-container-title:Nature Chem

Author:

Brem Jürgen,van Berkel Sander S.,Aik WeiShen,Rydzik Anna M.,Avison Matthew B.,Pettinati Ilaria,Umland Klaus-Daniel,Kawamura Akane,Spencer James,Claridge Timothy D. W.,McDonough Michael A.,Schofield Christopher J.

Publisher

Springer Science and Business Media LLC

Subject

General Chemical Engineering,General Chemistry

Link

http://www.nature.com/articles/nchem.2110.pdf

Reference35 articles.

1. Butler, M. S., Blaskovich, M. A. & Cooper, M. A. Antibiotics in the clinical pipeline in 2013. J. Antibiot. (Tokyo) 66, 571–591 (2013).

2. Bush, K. & Jacoby, G. A. Updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 54, 969–976 (2010).

3. Mattei, P. J., Neves, D. & Dessen, A. Bridging cell wall biosynthesis and bacterial morphogenesis. Curr. Opin. Struct. Biol. 20, 749–575 (2010).

4. Walsh, T. R., Toleman, M. A., Poirel, L. & Nordmann, P. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18, 306–325 (2005).

5. Cornaglia, G., Giamarellou, H. & Rossolini, G. M. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect. Dis. 11, 381–393 (2011).

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review;Pharmaceuticals;2024-08-23

2. Rhodanine derived enethiols react to give 1,3-dithiolanes and mixed disulfides;RSC Medicinal Chemistry;2024

3. Aurones and derivatives as promising New Delhi metallo-β-lactamase (NDM-1) inhibitors;Bioorganic & Medicinal Chemistry;2024-01

4. Cell-active small molecule inhibitors validate the SNM1A DNA repair nuclease as a cancer target;Chemical Science;2024

5. New 3-amino-2-thioxothiazolidin-4-one-based inhibitors of acetyl- and butyryl-cholinesterase: synthesis and activity;Future Medicinal Chemistry;2024-01